Aktie A2P061 BIOFORCE NANOSCIENCES HOLDINGS, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen BioForce Nanosciences Holdings, Inc.

Aktien

A2P061

US09064C2061

BFNH

Markt geschlossen - OTC Markets
Andere Börsenplätze
 19:35:13 25.06.2024 		% 5 Tage % 1. Jan.
1,85 USD -2,12 % Intraday Chart für BioForce Nanosciences Holdings, Inc. -.--% -7,96 %
03.05. BioForce Nanosciences Holdings, Inc. meldet Ergebnis für das erste Quartal zum 31. März 2024 CI
01.04. BioForce Nanosciences Holdings, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
BIOFORCE NANOSCIENCES HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
BioForce Nanosciences Holdings, Inc. Auditor Raises 'Going Concern' Doubt
BIOFORCE NANOSCIENCES HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
BIOFORCE NANOSCIENCES HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
BIOFORCE NANOSCIENCES HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q/A)
BIOFORCE NANOSCIENCES HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
BIOFORCE NANOSCIENCES HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
BioForce Nanosciences Holdings, Inc. Auditor Raises 'Going Concern' Doubt
BIOFORCE NANOSCIENCES HOLDINGS, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
BioForce Nanosciences Holdings, Inc. Announces CEO Changes
BioForce Nanosciences Holdings, Inc. Appoints Sasha Shapiro as President, Effective November 30, 2021
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2P061 Aktie
  4. Nachrichten BioForce Nanosciences Holdings, Inc.
  5. Andere Sprachen